[1] Blom H J, Smulders Y.Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects.[J]. Journal of Inherited Metabolic Disease, 2011, 34(1):75-81.
[2] Doolin M T, Barbaux S, Mcdonnell M, et al.Maternal Genetic Effects, Exerted by Genes Involved in Homocysteine Remethylation, Influence the Risk of Spina Bifida[J]. American Journal of Human Genetics, 2002, 71(5):1222-1226.
[3] O'Leary V B, Parlemcdermott A, Molloy A M, et al. MTRR and MTHFR polymorphism: link to Down syndrome[J]. American Journal of Medical Genetics Part B Neuropsychiatric Genetics, 2002, 107(2):151.
[4] Vijayakrishnan J, Houlston R S.Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: a systematic review and meta-analysis.[J]. 2010, 95(8):1405-1414.
[5] Cho N H, Lim S, Jang H C, et al.Elevated Homocysteine as a Risk Factor for the Development of Diabetes in Women with a Previous History of Gestational Diabetes Mellitus: A 4-year prospective study[J]. Diabetes Care, 2005, 28(11):2750-2755.
[6] Lannergard, A, Larsson A , Friman G , et al. Human serum amyloid A (SAA) and high sensitive C-reactive protein (hsCRP) in preterm newborn infants with nosocomial infections[J]. Acta Peadiatrica: promoting child health, 2008, 97(8):5.
[7] Veeranna V, Zalawadiya S K, Niraj A, et al.Homocysteine and Reclassification of Cardiovascular Disease Risk[J]. Journal of the American College of Cardiology, 2011, 58(10):1025-1033.
[8] Dominguez L J, Galioto A, Pineo A, et al.Age, homocysteine, and oxidative stress: relation to hypertension and type 2 diabetes mellitus.[J]. Journal of the American College of Nutrition, 2010, 29(1):1-6.
[9] Idzior-WaluaB, Cyganek K, Sztefko K, et al. Total plasma homocysteine correlates in women with gestational diabetes[J]. Archives of Gynecology & Obstetrics, 2008, 278(4):309-313. |
